Twist-1 Up-regulation in Carcinoma Correlates to Poor Survival

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2014 Nov 28

PMID 25429425

Citations 38

Authors

Alimujiang Wushou

Jing Hou

Ya-Jun Zhao

Zhi-Ming Shao

Affiliations

Soon will be listed here.

Abstract

Epithelial-to-mesenchymal transition (EMT) facilitates tumor metastasis. Twist is a basic helix-loop-helix protein that modulates many target genes through E-box-responsive elements. There are two twist-like proteins, Twist-1 and Twist-2, sharing high structural homology in mammals. Twist-1 was found to be a key factor in the promotion of metastasis of cancer cells, and is known to induce EMT. Twist-1 participation in carcinoma progression and metastasis has been reported in a variety of tumors. However, controversy exists concerning the correlation between Twist-1 and prognostic value with respect to carcinoma. A systematic review and meta-analysis were performed to determine whether the expression of Twist-1 was associated with the prognosis of carcinoma patients. This analysis included 17 studies: four studies evaluated lung cancer, three evaluated head and neck cancer, two evaluated breast cancer, two evaluated esophageal cancer, two evaluated liver cancer and one each evaluated osteosarcoma, bladder, cervical and ovarian cancer. A total of 2006 patients were enrolled in these studies, and the median trial sample size was 118 patients. Twist-1 expression was associated with worse overall survival (OS) at both 3 years (hazard ratio "HR" for death = 2.13, 95% CI = 1.86 to 2.45, p < 0.001) and 5 years (HR for death = 2.01, 95% CI = 1.76 to 2.29, p < 0.001). Expression of Twist-1 is associated with worse survival in carcinoma.

Citing Articles

Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis.

Nirala B, Yamamichi T, Petrescu D, Shafin T, Yustein J Cancers (Basel). 2023; 15(20).

PMID: 37894474 PMC: 10605493. DOI: 10.3390/cancers15205108.

The Triple Crown: NO, CO, and HS in cancer cell biology.

Oza P, Kashfi K Pharmacol Ther. 2023; 249:108502.

PMID: 37517510 PMC: 10529678. DOI: 10.1016/j.pharmthera.2023.108502.

Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer.

Raghu S, Bangalore Prabhashankar A, Shivanaiah B, Tripathi E, Sundaresan N Subcell Biochem. 2022; 100:337-360.

PMID: 36301499 DOI: 10.1007/978-3-031-07634-3_10.

Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis.

Fattahi F, Saeednejad Zanjani L, Vafaei S, Habibi Shams Z, Kiani J, Naseri M Diagn Pathol. 2021; 16(1):26.

PMID: 33752711 PMC: 7983220. DOI: 10.1186/s13000-021-01088-1.

Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Banyai L, Trexler M, Kerekes K, Csuka O, Patthy L Elife. 2021; 10.

PMID: 33427197 PMC: 7877913. DOI: 10.7554/eLife.59629.

References

Lee K, Kim J, Han S, Sung C, Do I, Ko Y . Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Ann Surg Oncol. 2011; 19(1):326-35. DOI: 10.1245/s10434-011-1867-0. View

Jouppila-Matto A, Narkio-Makela M, Soini Y, Pukkila M, Sironen R, Tuhkanen H . Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer. 2011; 11:350. PMC: 3173446. DOI: 10.1186/1471-2407-11-350. View

Parmar M, Torri V, Stewart L . Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1999; 17(24):2815-34. DOI: 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8. View

Hung J, Yang M, Hsu H, Hsu W, Liu J, Wu K . Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax. 2009; 64(12):1082-9. DOI: 10.1136/thx.2009.115691. View

Li L, Cserjesi P, Olson E . Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev Biol. 1995; 172(1):280-92. DOI: 10.1006/dbio.1995.0023. View

Jiang W, Pang X, Wang Q, Shen Y, Chen X, Xi J . Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Clin Lung Cancer. 2011; 13(4):280-7. DOI: 10.1016/j.cllc.2011.11.005. View

Kyo S, Sakaguchi J, Ohno S, Mizumoto Y, Maida Y, Hashimoto M . High Twist expression is involved in infiltrative endometrial cancer and affects patient survival. Hum Pathol. 2006; 37(4):431-8. DOI: 10.1016/j.humpath.2005.12.021. View

Niu R, Zhang L, Xi G, Wei X, Yang Y, Shi Y . Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2007; 26(3):385-94. View

Fondrevelle M, Kantelip B, Reiter R, Chopin D, Thiery J, Monnien F . The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol. 2008; 27(3):268-76. DOI: 10.1016/j.urolonc.2007.12.012. View

10.

Pallier K, Cessot A, Cote J, Just P, Cazes A, Fabre E . TWIST1 a new determinant of epithelial to mesenchymal transition in EGFR mutated lung adenocarcinoma. PLoS One. 2012; 7(1):e29954. PMC: 3260187. DOI: 10.1371/journal.pone.0029954. View

11.

Wushou A, Pan H, Liu W, Tian Z, Wang L, Shali S . Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg. 2011; 70(6):1473-9. DOI: 10.1016/j.joms.2011.06.212. View

12.

Hui L, Zhang S, Dong X, Tian D, Cui Z, Qiu X . Prognostic significance of twist and N-cadherin expression in NSCLC. PLoS One. 2013; 8(4):e62171. PMC: 3633889. DOI: 10.1371/journal.pone.0062171. View

13.

Zhao X, Sun T, Che N, Sun D, Zhao N, Dong X . Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. J Cell Mol Med. 2010; 15(3):691-700. PMC: 3922390. DOI: 10.1111/j.1582-4934.2010.01052.x. View

14.

Zhao M, Hu H, Huang J, Zou Q, Wang J, Liu M . Expression and correlation of Twist and gelatinases in breast cancer. Exp Ther Med. 2013; 6(1):97-100. PMC: 3735531. DOI: 10.3892/etm.2013.1099. View

15.

Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P . Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer. 2011; 11:73. PMC: 3055233. DOI: 10.1186/1471-2407-11-73. View

16.

Chiang S, Han C, Yu K, Chen Y, Wu K . Prioritization of cancer marker candidates based on the immunohistochemistry staining images deposited in the human protein atlas. PLoS One. 2013; 8(11):e81079. PMC: 3841220. DOI: 10.1371/journal.pone.0081079. View

17.

Hosono S, Kajiyama H, Terauchi M, Shibata K, Ino K, Nawa A . Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients. Br J Cancer. 2007; 96(2):314-20. PMC: 2360014. DOI: 10.1038/sj.bjc.6603533. View

18.

Yin K, Liao Q, He H, Zhong D . Prognostic value of Twist and E-cadherin in patients with osteosarcoma. Med Oncol. 2012; 29(5):3449-55. DOI: 10.1007/s12032-012-0317-6. View

19.

Zhang D, Sun B, Zhao X, Ma Y, Ji R, Gu Q . Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer. Mol Cancer. 2014; 13:207. PMC: 4168051. DOI: 10.1186/1476-4598-13-207. View

20.

Sasaki K, Natsugoe S, Ishigami S, Matsumoto M, Okumura H, Setoyama T . Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2009; 28:158. PMC: 2808309. DOI: 10.1186/1756-9966-28-158. View